Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of its most commonly used components by sponsors and CROs is limited and perceptions of their benefits are still varied, new findings show
Despite the push for greater use of risk-based quality management (RBQM) in clinical research, adoption of its most commonly used components by sponsors and CROs is limited and perceptions of their benefits are still varied, new findings show
